Litcius/Paper detail

Type I CRISPR-Cas provides robust immunity but incomplete attenuation of phage-induced cellular stress

Lucía M. Malone, Hannah G. Hampton, Xochitl C. Morgan, Peter C. Fineran

2021Nucleic Acids Research34 citationsDOIOpen Access PDF

Abstract

During infection, phages manipulate bacteria to redirect metabolism towards viral proliferation. To counteract phages, some bacteria employ CRISPR-Cas systems that provide adaptive immunity. While CRISPR-Cas mechanisms have been studied extensively, their effects on both the phage and the host during phage infection remains poorly understood. Here, we analysed the infection of Serratia by a siphovirus (JS26) and the transcriptomic response with, or without type I-E or I-F CRISPR-Cas immunity. In non-immune Serratia, phage infection altered bacterial metabolism by upregulating anaerobic respiration and amino acid biosynthesis genes, while flagella production was suppressed. Furthermore, phage proliferation required a late-expressed viral Cas4 homologue, which did not influence CRISPR adaptation. While type I-E and I-F immunity provided robust defence against phage infection, phage development still impacted the bacterial host. Moreover, DNA repair and SOS response pathways were upregulated during type I immunity. We also discovered that the type I-F system is controlled by a positive autoregulatory feedback loop that is activated upon phage targeting during type I-F immunity, leading to a controlled anti-phage response. Overall, our results provide new insight into phage-host dynamics and the impact of CRISPR immunity within the infected cell.

Topics & Concepts

BiologyCRISPRImmunityMicrobiologyBacteriophageImmune systemAcquired immune systemBacteriaVirologyGeneGeneticsEscherichia coliCRISPR and Genetic EngineeringBacteriophages and microbial interactionsCytomegalovirus and herpesvirus research
Type I CRISPR-Cas provides robust immunity but incomplete attenuation of phage-induced cellular stress | Litcius